Comparison of the long-term tolerability, pharmacodynamics, and safety of Sandimmune and Neoral in liver transplant recipients. Ontario Liver Transplant Study Group

Transplant Proc. 1996 Aug;28(4):2232-3.
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Adult
  • Aged
  • Antilymphocyte Serum / therapeutic use
  • Cyclosporine / administration & dosage
  • Cyclosporine / pharmacokinetics
  • Cyclosporine / therapeutic use*
  • Dosage Forms
  • Drug Therapy, Combination
  • Follow-Up Studies
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / pharmacokinetics
  • Immunosuppressive Agents / therapeutic use*
  • Liver Transplantation / immunology*
  • Liver Transplantation / mortality
  • Liver Transplantation / physiology
  • Methylprednisolone / therapeutic use
  • Middle Aged
  • Muromonab-CD3 / therapeutic use
  • Reoperation
  • Survival Rate

Substances

  • Antilymphocyte Serum
  • Dosage Forms
  • Immunosuppressive Agents
  • Muromonab-CD3
  • Cyclosporine
  • Methylprednisolone